Brought to you by 
Lion Bioscience licenses bioinformatics tool from EMBL
17 Mar 2004
Executive Summary
Lion Bioscience AG has acquired an exclusive commercial license for the sequence retrieval system (SRS), a bioinformatics tool developed by the European Molecular Biology Laboratory (EMBL, a nonprofit research organization).
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Lion Bioscience licenses bioinformatics tool from EMBL
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice